Although a clear advantage of concurrent radio-chemotherapy in terms of PFS and OS is missing in this cohort, the data suggests that treatment according to Stupp protocol should be considered as a valuable option for patients with IDH wt astrocytoma. The gene discussed is IDH1; the disease is astrocytoma (excluding glioblastoma).